This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Mattress Firm Leads Fight Against Pancreatic Cancer

Stocks in this article: MFRM

Mattress Firm (NASDAQ: MFRM), the nation’s largest specialty retailer of mattresses and accessories, announced today that it is launching several initiatives to support Pancreatic Cancer Awareness month this November.

Pancreatic Cancer is Mattress Firm’s national charitable focus, which the company supports through its Mattress Firm Foundation organization. Mattress Firm Foundation was established in 2011, in response to the tremendous need for funding, research and awareness. The organization has since contributed close to $600K and thousands of volunteer hours towards pancreatic cancer research and awareness.

The Mattress Firm Foundation plays a significant role in the fight against Pancreatic Cancer, the most under-funded, under-recognized and least-studied of all major cancers. Pancreatic Cancer receives only two percent of the National Cancer Institute's annual budget for research, so a cure for the disease depends on outside support and contributions.

For Pancreatic Cancer Awareness Month this November, Mattress Firm will launch the following initiatives:

Mattress Firm’s New Lux Living Pillow, Proceeds to Benefit Pancreatic Cancer ResearchOn November 5th, Mattress Firm will debut a new pillow in its Lux Living line. A portion of the proceeds from the sale of the new pillows will go to Mattress Firm Foundation which supports pancreatic cancer research and awareness. The Lux Living pillow is made of advanced memory foam to relieve pressure, stress and tension in the neck and shoulders. The top layer of cooling Lux Gel works to improve circulation. The pillow is available at all Mattress Firm stores and online at

Serta to Donate a Portion of Sales Proceeds from iComfort BedMattress manufacturer Serta has agreed to donate a portion of the proceeds from each iComfort sold during the month of November to the Mattress Firm Foundation for a total of $25,000. Mattress Firm has committed to matching that donation for a total of $50,000.

Local Community Event/ Purple Stride WalksMattress Firm has more than 1,000 stores in 28 states, and over 2500 employees around the country that host fundraisers and participate in events that support pancreatic cancer research and awareness. Employees in 25 major markets actively participate in Pancreatic Cancer Action Network’s PurpleStride walks, awareness nights and over 450 employees participated in the National Call-In this past June.

For more information on Mattress Firm Foundation, please visit:

About Mattress Firm:

Houston-based Mattress Firm (NASDAQ: MFRM) is a high growth specialty retailer, recognized as one of the nation’s largest specialty bedding companies, offering a broad selection of both traditional and specialty mattresses, bedding accessories and related products from leading manufacturers. With more than 1000 stores across 28 states, Mattress Firm has the largest geographic footprint in the United States among mattress specialty retailers. Mattress Firm offers customers comfortable store environments, guarantees on price, comfort and service, and highly-trained sales professionals.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs